Madrid, August 23, 2018.- Ozone therapy is practiced in Spain as a complementary, coadjuvant or palliative treatment for various diseases, according to the latest report published by AEPROMO (Spanish Association of Medical Professionals in Ozone Therapy). A total of 15 autonomous communities in written responses to Aepromo have established the criteria for the practice of ozone therapy, and 23 pain units and two diabetic foot of Spanish public hospitals have included it in their services.
The Spanish Agency of Medicines and Medical Devices (AEMPS for its Spanish acronym) has also authorized in Spain the realization of two clinical trials with ozone and a post-authorization prospective monitoring study (EPA-SP for its Spanish acronym).
At an international level ozone therapy keeps creating interest among medical professionals and MedLine currently accounts for 3,153 records, of which 235 are clinical studies published in PubMed. The European Medicines Agency (EMA) includes ozone as an authorized active substance and also it has active projects in research
(https://eudract.ema.europa.eu/results-web).
This content is also available in: Spanish
